Hospital Clínico Universidad de Chile

Santiago 8380456

0 studies enrolling now · 5 studies all time

What they study most

Biliary Tract Cancer, Cholangiocarcinoma, Cirrhosis, First Line Non-Small Cell Lung Cancer, Gallbladder Cancer, NASH - Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Prevention of Esophageal Varices, Primary Biliary Cirrhosis

Studies at this site

• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) — Running, not enrolling
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis — Stopped early
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early